Kolaleh Eskandanian, Ph.D., M.B.A., during her recent appearance at POLITICO.

In the news: The future of patient care and access

Kolaleh Eskandanian, Ph.D., M.B.A., during her recent appearance at POLITICO.

“It is a market failure that we are dealing with – a lack of incentives leading to a stagnation in innovation with respect to small markets, such as pediatrics. Children’s National Hospital and our partners in other children’s hospitals in the country play a critical role in making noise and sending a message that children should not be an afterthought.” 

Hear more from Kolaleh Eskandanian, Ph.D., M.B.A., during her recent appearance at POLITICO. As vice president and chief innovation officer at Children’s National and Alliance for Pediatric Device Innovation principal investigator, Dr. Eskandanian shared her approach to engaging with the Food and Drug Administration (FDA) to advance artificial intelligence (AI) and machine learning technologies for pediatric healthcare. To date, she noted, the FDA has authorized 950 healthcare-related technologies enabled with AI and machine learning.

You might also like
mother with newborn babyPerinatal Mood and Anxiety Lab to launch at Children’s National
2023 with a lightbulbThe best of 2023 from Innovation District
little boy at doctorDemographic, clinical and biomarker features of MIS-C
Motor neuron connecting to muscle fiberFDA approves muscular dystrophy drug built on Children’s National research
Leaders from pediatric healthcare, federal organizations, academia, industry and patient advocacy groups gathered at the Children’s National Research & Innovation Campus.Access4Kids: A new model to pay for pediatric cell and gene therapies
mother kissing newborn babyEvidence review: Maternal mental conditions drive climbing death rate in U.S.